Invention Grant
- Patent Title: Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies
-
Application No.: US14334773Application Date: 2014-07-18
-
Publication No.: US09714949B2Publication Date: 2017-07-25
- Inventor: Elke Faatz , Peter Schaarschmidt , Urban Schmitt , Christian Scholz
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Roche Diagnostics Operations, Inc.
- Priority: EP13003633 20130718
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68 ; C07K14/28 ; G01N33/571 ; C07K14/245

Abstract:
The invention relates to a method for detecting antibodies against the TpN17 antigen of Treponema pallidum in an isolated sample wherein a peptide sequence of Vibrio cholerae lipoprotein 15 (VcLp15) or a partial sequence thereof is used as a reagent for reduction of interference, i.e. for minimizing false positive results. In addition the invention relates to fusion polypeptides comprising a VcLp15 peptide sequence and a chaperone, to their use as an additive in an immunoassay for said reduction of interferences and for minimizing false positive results and to a reagent kit for detecting antibodies against Treponema pallidum antigens in an isolated sample comprising a TpN17 antigen and said VcLp15-chaperone fusion polypeptide.
Public/Granted literature
Information query
IPC分类: